XPREZA contains Drug / Molecule Azacitidine.
USAGE & DESCRIPTION :
XPREZA has used for treatment of patients with the following Myelodysplastic Syndrome , Refractory Anemia (RA).
INTERNATIONAL BRAND NAME
SINGLE USE VIAL
NATCO PHARMA LIMITED. (INDIA)
CLINICAL APPLICATIONS :
It is a cytosine nucleoside nucleoside analogs that become incorporated into newly synthesized RNA and DNA. The incorporation into RNA leads to defective methylation and inhibition of the production of protein. It significantly induced DNA damage and apoptosis.
Store at room temperature (25°C).